Ideaya Biosciences Inc
IDYA
Market Cap$2.15B
Close$
$-1.57
105.8% downside
Current Fair Value
105.8% downsideOvervalued by 105.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.15 Billion |
|---|---|
| Enterprise Value | $2.08 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.36 |
| Beta | 0.09 |
| Outstanding Shares | 88,472,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.56 |
|---|---|
| PEG | -14.01 |
| Price to Sales | - |
| Price to Book Ratio | 2.72 |
| Enterprise Value to Revenue | 297.27 |
| Enterprise Value to EBIT | -5.42 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ideaya Biosciences Inc
CEO: Yujiro Hata